Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy

Clinical trial NCT00364351 · COMPLETED

Trial details

NCT number: NCT00364351
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2006-08-01
Primary completion: 2008-09-01
Enrollment: 1574

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.